Ning Z. Wu
Expertise in
28
conditions

Dr. Ning Z. Wu

Urology
22285 N Pepper Rd, Ste 201, 
Lake Barrington, IL 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
28
conditions
22285 N Pepper Rd, Ste 201, 
Lake Barrington, IL 

Overview

Ning Z. Wu, MD, is a board-certified, independent urologist at Ascension Illinois in Lake Barrington, near Chicago, Illinois. Dr. Wu diagnoses and treats genitourinary conditions, including leaky bladder, frequent urinary tract infections (UTI), blood in the urine, enlarged prostate, erectile dysfunction (ED), incontinence and pelvic health disorders. Dr. Wu takes the time to get to know you and your concerns. Then, Dr. Wu works with you to create a personalized care plan.

Dr. Wu is highly rated in 28 conditions, according to our data. His clinical expertise encompasses UPJ Obstruction, Perirenal Abscess, Boils, Ureteroscopy, and Prostatectomy.

Dr. Wu is board certified in American Board Of Urology and The American Board Of Urology - Urology. He is actively involved in clinical research, co-authoring 122 peer reviewed articles and participating in 6 clinical trials. Dr. Wu is currently accepting new patients.

Specialties

Urology

Licenses

Urology in IL

Board Certifications

American Board Of Urology
The American Board Of Urology - Urology

Hospital Affiliations

Ascension Saint Alexius
St Alexius Medical Center
Northwest Community Hospital 1
Advocate Sherman Hospital
Northwestern Medicine Central Dupage Hospital
Advocate Good Shepherd Hospital

Languages Spoken

English
Mandarin

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sutter Health
  • HMO
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 19 Less Insurance Carriers -

Locations

Comprehensive Urologic Care, SC
22285 N Pepper Rd, Ste 201, Lake Barrington, IL 60010

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Prospective, Multicenter, Double Blind, Randomized, Clinical Study to Evaluate the Safety and Efficacy of the Optilume™ BPH Catheter System in Men With Symptomatic BPH
A Prospective, Multicenter, Double Blind, Randomized, Clinical Study to Evaluate the Safety and Efficacy of the Optilume™ BPH Catheter System in Men With Symptomatic BPH
Enrollment Status: Active_not_recruiting
Publish Date: July 30, 2026
Intervention Type: Device
Study Phase: Not Applicable
A Prospective Study to Assess the Efficacy and Safety of the BlueWind RENOVA iStim™ System in the Treatment of Patients Diagnosed With Overactive Bladder (OASIS - OverActive Bladder StImulation System Study)
A Prospective Study to Assess the Efficacy and Safety of the BlueWind RENOVA iStim™ System in the Treatment of Patients Diagnosed With Overactive Bladder (OASIS - OverActive Bladder StImulation System Study)
Enrollment Status: Completed
Publish Date: September 16, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Controlled, Open-Label Study of the Efficacy, Durability, and Safety of UGN-102 With or Without TURBT in Patients With Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
A Randomized, Controlled, Open-Label Study of the Efficacy, Durability, and Safety of UGN-102 With or Without TURBT in Patients With Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
Enrollment Status: Terminated
Publish Date: June 06, 2024
Intervention Type: Drug, Procedure
Study Drug: Mitomycin C
Study Phase: Phase 3
VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent
VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent
Enrollment Status: Terminated
Publish Date: February 05, 2024
Intervention Type: Drug
Study Drugs: VERU-111, Enzalutamide, Abiraterone, Darolutamide and Apalutamide
Study Phase: Phase 3
Open-Label, Proof-of-Concept and Dose Finding Phase 1b/2 Study of VERU-100 in Men With Advanced Prostate Cancer
Open-Label, Proof-of-Concept and Dose Finding Phase 1b/2 Study of VERU-100 in Men With Advanced Prostate Cancer
Enrollment Status: Terminated
Publish Date: May 19, 2023
Intervention Type: Drug
Study Drug: VERU-100
Study Phase: Phase 1/Phase 2
A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer
A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer
Enrollment Status: Terminated
Publish Date: August 28, 2019
View 5 Less Clinical Trials

122 Total Publications

12-Month Outcomes From a Randomized, Sham-Controlled Trial Evaluating a Novel Prostatic Urethral Stent for the Treatment of Benign Prostatic Hyperplasia.
12-Month Outcomes From a Randomized, Sham-Controlled Trial Evaluating a Novel Prostatic Urethral Stent for the Treatment of Benign Prostatic Hyperplasia.
Journal: The Journal of urology
Published: December 15, 2025
Similar Doctors
Expertise in
38
conditions
Expertise in
38
conditions
Referral may be required
Before you request

Endeavor Health Medical Group

2180 Pfingsten Rd., Suite 3000, 
Glenview, IL 
 (18.0 miles away)
847-503-3000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Brian T. Helfand, MD, a urologist at Endeavor Health, specializes in urologic oncology and the treatment of prostate conditions. His clinical expertise includes minimally invasive surgery, advanced laparoscopy and procedures using the da Vinci robotic system. Dr. Helfand treats conditions such as benign prostatic hyperplasia, prostate cancer and urinary dysfunction using personalized and evidence-based approaches. Dr. Helfand is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Aquablation, and Prostatectomy. Dr. Helfand is board certified in American Board Of Urology. Dr. Helfand is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required

UroPartners Surgery Center

2750 S River Rd, 
Des Plaines, IL 
 (20.7 miles away)
224-612-7000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Laurence Levine is a Urologist practicing medicine in Des Plaines, Illinois. Dr. Levine is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Peyronie Disease, Priapism, Erectile Dysfunction (ED), Vasectomy, and Reconstructive Urology Surgery. Dr. Levine is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required
Before you request
675 N St Clair St Ste 20-150, Galter Pavilion, 
Chicago, IL 
 (35.5 miles away)
312-695-8146
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Amy Krambeck is a Urologist practicing medicine in Chicago, Illinois. Dr. Krambeck is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Enlarged Prostate (BPH), Kidney Stones, Bladder Stones, Ureteroscopy, and Lithotripsy. Dr. Krambeck is board certified in American Board Of Urology - Urology (Certified). Dr. Krambeck is currently accepting new patients.

Frequently Asked Questions about Dr. Ning Z. Wu

How do I make an appointment with Dr. Ning Z. Wu?

You can book an appointment with Dr. Ning Z. Wu by calling their office at 847-382-5080. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ning Z. Wu a top-rated expert for UPJ Obstruction?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ning Z. Wu is classified as an Distinguished expert for UPJ Obstruction, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ning Z. Wu specialize in?

While Dr. Ning Z. Wu is a Urology, they have specific expertise in UPJ Obstruction, Perirenal Abscess, and Boils. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Ning Z. Wu participate in research or clinical trials?

Yes. Dr. Ning Z. Wu has published 122 articles and abstracts on conditions like UPJ Obstruction. You can view a list of Dr. Ning Z. Wu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ning Z. Wu accept my insurance?

Dr. Ning Z. Wu accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 847-382-5080 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wu's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 19 Advanced Conditions
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile